Apheris vs Desupervised

<p>Apheris is a drug discovery software platform designed to advance pharmaceutical research by providing secure, local AI-driven model deployment and benchmarking. It empowers drug discovery teams to run and customize AI models in their own environment, ensuring proprietary data remains in-house. The platform supports federated data networks, enabling multiple organizations to collaboratively train and improve drug discovery models without sharing sensitive information.</p> <p>With Apheris, you can join or build federated networks spanning leading biopharma companies, fine-tune models on your own data, and integrate results via GUI or API for streamlined discovery workflows. It offers benchmarking capabilities on internal datasets, helps design more informative experimental batches, and facilitates collaboration across research teams. This powerful combination enhances your ability to develop better medicines faster while maintaining data security and control.</p>

<p>Desupervised is an AI-focused technology platform designed to make advanced analytics accessible to everyday users. It offers bespoke AI solutions tailored to your specific needs, empowering you to leverage state-of-the-art models for better, faster decision-making across many industries. Whether you need predictive insights into commercial activities or custom AI-driven workflows, Desupervised supports your goals.</p> <p>With products like Alviss, their predictive analytics platform, you gain real-time AI insights to drive your business forward. They also specialize in speeding up drug discovery through Bayesian Deep Virtual Screening, highlighting their strength in niche AI applications. Serving multiple markets since 2018 with over 2100 deployed models, Desupervised combines flexibility and expertise, making AI approaches practical and impactful for your operations.</p>